{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:12:56Z","timestamp":1791825176815,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1124\/jpet.110.170225","type":"journal-article","created":{"date-parts":[[2010,7,13]],"date-time":"2010-07-13T21:00:42Z","timestamp":1279054842000},"page":"32-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation"],"prefix":"10.1016","volume":"335","author":[{"given":"Jie","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yatrik M.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher W.","family":"Krausz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank J.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.110.170225_bib1","first-page":"1391","article-title":"A case of rifampicin induced pseudomembraneous colitis","volume":"24","author":"Akbar","year":"2003","journal-title":"Saudi Med J"},{"key":"10.1124\/jpet.110.170225_bib2","doi-asserted-by":"crossref","first-page":"12208","DOI":"10.1073\/pnas.95.21.12208","article-title":"Identification of a human nuclear receptor defines a new signaling pathway for CYP3A induction","volume":"95","author":"Bertilsson","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.110.170225_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cmet.2007.12.003","article-title":"Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 down-regulation exacerbates inflammation and acute colitis","volume":"7","author":"Chen","year":"2008","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.110.170225_bib4","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/MAJ.0b013e31819f1eec","article-title":"Rifampin-associated pseudomembranous colitis","volume":"338","author":"Chen","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1124\/jpet.110.170225_bib5","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1124\/dmd.109.027565","article-title":"Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.170225_bib6","first-page":"238","article-title":"Clinicopathologic study of dextran sulfate sodium experimental murine colitis","volume":"69","author":"Cooper","year":"1993","journal-title":"Lab Invest"},{"key":"10.1124\/jpet.110.170225_bib7","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10620-010-1140-6","article-title":"Rifaximin and Crohn\u2019s disease: a new solution to an old problem?","volume":"55","author":"Day","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.110.170225_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1053\/j.gastro.2005.12.008","article-title":"The pregnane X receptor locus is associated with susceptibility to inflammatory bowel disease","volume":"130","author":"Dring","year":"2006","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"10.1124\/jpet.110.170225_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000089782","article-title":"Antimicrobials in the management of inflammatory bowel disease","volume":"73","author":"Gionchetti","year":"2006","journal-title":"Digestion"},{"key":"10.1124\/jpet.110.170225_bib10","doi-asserted-by":"crossref","first-page":"17882","DOI":"10.1074\/jbc.M601302200","article-title":"Role of NF-\u03baB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents","volume":"281","author":"Gu","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.110.170225_bib11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000068143","article-title":"Animal models of inflammatory bowel disease: an overview","volume":"70","author":"Hoffmann","year":"2002","journal-title":"Pathobiology"},{"key":"10.1124\/jpet.110.170225_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/mend.14.1.0409","article-title":"The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution","volume":"14","author":"Jones","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1124\/jpet.110.170225_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1146\/annurev-immunol-030409-101225","article-title":"Inflammatory bowel disease","volume":"28","author":"Kaser","year":"2010","journal-title":"Annu Rev Immunol"},{"key":"10.1124\/jpet.110.170225_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/MOG.0b013e328333dc8d","article-title":"Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases","volume":"26","author":"Koo","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1124\/jpet.110.170225_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.gastro.2004.04.019","article-title":"Loss of detoxification in inflammatory bowel disease: dysregulation of pregnane X receptor target genes","volume":"127","author":"Langmann","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1124\/jpet.110.170225_bib16","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00006205-200502000-00004","article-title":"2004 drug approval highlights: FDA update","volume":"30","author":"Laustsen","year":"2005","journal-title":"Nurse Pract"},{"key":"10.1124\/jpet.110.170225_bib17","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1517\/17425255.4.7.895","article-title":"The pregnane X receptor: from bench to bedside","volume":"4","author":"Ma","year":"2008","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1124\/jpet.110.170225_bib18","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1124\/dmd.106.012831","article-title":"The pregnane X receptor gene-humanized mouse: a model for investigating drug-drug interactions mediated by cytochromes P450 3A","volume":"35","author":"Ma","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/jpet.110.170225_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1124\/jpet.107.121913","article-title":"Rifaximin is a gut-specific human pregnane X receptor activator","volume":"322","author":"Ma","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.110.170225_bib20","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/jm00145a020","article-title":"4-Deoxypyrido[1\u2032,2\u2032:1,2]imidazo[5,4-c]rifamycin SV derivatives. A new series of semisynthetic rifamycins with high antibacterial activity and low gastroenteric absorption","volume":"28","author":"Marchi","year":"1985","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.110.170225_bib21","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.7205\/MILMED.173.11.1145","article-title":"Acute brucellosis as a cause of infective colitis","volume":"173","author":"Mazokopakis","year":"2008","journal-title":"Mil Med"},{"key":"10.1124\/jpet.110.170225_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/MPG.0b013e3181a0d269","article-title":"Use and safety of rifaximin in children with inflammatory bowel disease","volume":"49","author":"Muniyappa","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1124\/jpet.110.170225_bib23","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s10620-009-1111-y","article-title":"Adjunctive antibiotic therapy with rifaximin may help reduce Crohn\u2019s disease activity","volume":"55","author":"Shafran","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.110.170225_bib24","doi-asserted-by":"crossref","first-page":"G1114","DOI":"10.1152\/ajpgi.00528.2006","article-title":"Pregnane X receptor activation ameliorates DSS-induced inflammatory bowel disease via inhibition of NF-\u03baB target gene expression","volume":"292","author":"Shah","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/jpet.110.170225_bib25","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2174\/156652409788970652","article-title":"The signaling function of the IL-13R\u03b12 receptor in the development of gastrointestinal fibrosis and cancer surveillance","volume":"9","author":"Strober","year":"2009","journal-title":"Curr Mol Med"},{"key":"10.1124\/jpet.110.170225_bib26","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1440-1746.2007.05207.x","article-title":"Antituberculosis drug-induced hepatotoxicity: concise up-to-date review","volume":"23","author":"Tostmann","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1124\/jpet.110.170225_bib27","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1038\/ajg.2009.270","article-title":"A randomized, double-blind, placebo-controlled trial of rifaximin, a nonabsorbable antibiotic, in the treatment of tropical enteropathy","volume":"104","author":"Trehan","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/jpet.110.170225_bib28","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.08.004","article-title":"Xenobiotic receptor meets NF-\u03baB, a collision in the small bowel","volume":"4","author":"Xie","year":"2006","journal-title":"Cell Metab"},{"key":"10.1124\/jpet.110.170225_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/35019116","article-title":"Humanized xenobiotic response in mice expressing nuclear receptor SXR","volume":"406","author":"Xie","year":"2000","journal-title":"Nature"},{"key":"10.1124\/jpet.110.170225_bib30","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10620-007-9839-8","article-title":"Rifaximin versus other antibiotics in the primary treatment and retreatment of bacterial overgrowth in IBS","volume":"53","author":"Yang","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1124\/jpet.110.170225_bib31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1128\/AAC.00961-08","article-title":"Roles of NF-\u03baB activation and peroxisome proliferator-activated receptor \u03b3 inhibition in the effect of rifampin on inducible nitric oxide synthase transcription in human lung epithelial cells","volume":"53","author":"Yuhas","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/jpet.110.170225_bib32","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1172\/JCI26283","article-title":"Mutual repression between steroid and xenobiotic receptor and NF-\u03baB signaling pathways links xenobiotic metabolism and inflammation","volume":"116","author":"Zhou","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.110.170225_bib33","doi-asserted-by":"crossref","first-page":"e001","DOI":"10.1621\/nrs.07001","article-title":"The steroid and xenobiotic receptor (SXR), beyond xenobiotic metabolism","volume":"7","author":"Zhou","year":"2009","journal-title":"Nucl Recept Signal"},{"key":"10.1124\/jpet.110.170225_bib34","doi-asserted-by":"crossref","first-page":"15013","DOI":"10.1074\/jbc.M511116200","article-title":"A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway","volume":"281","author":"Zhou","year":"2006","journal-title":"J Biol Chem"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524460461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524460461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.110.170225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:19:00Z","timestamp":1739999940000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524460461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0022356524460461"],"URL":"https:\/\/doi.org\/10.1124\/jpet.110.170225","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic Role of Rifaximin in Inflammatory Bowel Disease: Clinical Implication of Human Pregnane X Receptor Activation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.110.170225","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}